This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
  2. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  3. Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan
  4. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  5. Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
  6. Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
  7. Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
  8. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  9. Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
  10. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  11. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  12. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan
  13. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  14. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan
  15. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  16. Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  17. Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, Taiwan
  18. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
  19. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan
  20. Corresponding author: Mu-Hong Chen, MD, PhD, Department of Psychiatry, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd, Beitou District, Taipei City, Taiwan 11217, ROC ([email protected]).
  1. Dai YX, Chen TJ, Chang YT. Ambulatory practice of dermatologists in Taiwan: a nationwide survey. J Chin Med Assoc. 2018;81(8):729–734. PubMed CrossRef
  2. Dai Y-X, Chen T-J, Chang Y-T. Skin care services and disease prevalence in Taiwan: a nationwide study. Zhonghua Pifuke Yixue Zazhi. 2018;36(3):124–130. CrossRef
  3. Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70(7):628–633. PubMed CrossRef
  4. Phototherapy for vitiligo. Drug Ther Bull. 2017;55(6):65. PubMed
  5. Pratt CH, King LE Jr, Messenger AG, et al. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011. PubMed CrossRef
  6. Dai Y-X, Yeh C-P, Chen C-C. Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata. Dermatological Sinica. 2020;38(1):3–8.
  7. Titeca G, Goudetsidis L, Francq B, et al. ‘The psychosocial burden of alopecia areata and androgenetica’: a cross-sectional multicentre study among dermatological out-patients in 13 European countries. J Eur Acad Dermatol Venereol. 2020;34(2):406–411. PubMed CrossRef
  8. Marahatta S, Agrawal S, Adhikari BR. Psychological impact of alopecia areata. Dermatol Res Pract. 2020;2020:8879343. PubMed CrossRef
  9. Lee S, Lee H, Lee CH, et al. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466–477.e16. PubMed CrossRef
  10. Barahmani N, Schabath MB, Duvic M; National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581–591. PubMed CrossRef
  11. Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949–956. PubMed CrossRef
  12. Dai YX, Tai YH, Chang YT, et al. Increased risk of alopecia areata among patients with endometriosis: a longitudinal study in Taiwan. Dermatologica Sinica. 2021;39(1):41–44.
  13. Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018;131(10):1161–1169. PubMed CrossRef
  14. Atzeni F, Pipitone N, Iaccarino L, et al. Rheumatic diseases and autoimmune vascular dementia. Autoimmun Rev. 2017;16(12):1265–1269. PubMed CrossRef
  15. Li X, Sundquist J, Zöller B, et al. Dementia and Alzheimer’s disease risks in patients with autoimmune disorders. Geriatr Gerontol Int. 2018;18(9):1350–1355. PubMed CrossRef
  16. Lin TM, Chen WS, Sheu JJ, et al. Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: a nationwide cohort study. PLoS One. 2018;13(1):e0186475. PubMed CrossRef
  17. Wotton CJ, Goldacre MJ. Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK. J Epidemiol Community Health. 2017;71(6):576–583. PubMed CrossRef
  18. Gendelman O, Tiosano S, Shoenfeld Y, et al. High proportions of dementia among SLE patients: a big data analysis. Int J Geriatr Psychiatry. 2018;33(3):531–536. PubMed CrossRef
  19. D’Andrea MR. Add Alzheimer’s disease to the list of autoimmune diseases. Med Hypotheses. 2005;64(3):458–463. PubMed CrossRef
  20. Sardi F, Fassina L, Venturini L, et al. Alzheimer’s disease, autoimmunity and inflammation: the good, the bad and the ugly. Autoimmun Rev. 2011;11(2):149–153. PubMed CrossRef
  21. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol. 2004;61(5):668–672. PubMed CrossRef
  22. Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73(10):768–774. PubMed CrossRef
  23. Tazi-Ahnini R, McDonagh AJ, Cox A, et al. Association analysis of IL1A and IL1B variants in alopecia areata. Heredity. 2001;87(pt 2):215–219. PubMed CrossRef
  24. Penninkilampi R, Casey AN, Singh MF, et al. The association between social engagement, loneliness, and risk of dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2018;66(4):1619–1633. PubMed CrossRef
  25. Dai YX, Wang SC, Chou YJ, et al. Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study. J Am Acad Dermatol. 2019;80(3):727–734. PubMed CrossRef
  26. Li CY, Dai YX, Chen YJ, et al. Cancer risks in vitiligo patients: a nationwide population-based study in Taiwan. Int J Environ Res Public Health. 2018;15(9):1847. PubMed CrossRef
  27. Lo PC, Li CY, Huang WF, et al. Risk of fractures in vitiligo patients treated with phototherapy—a retrospective population-based cohort study. J Dermatol Sci. 2016;82(3):197–203. PubMed CrossRef
  28. Dai YX, Chen CC, Tai YH, et al. Increased risk of major depressive disorder among probands with psoriasis and unaffected siblings: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2020;34(7):1510–1515. PubMed CrossRef
  29. Dai YX, Tai YH, Chen CC, et al. Bidirectional association between alopecia areata and major depressive disorder among probands and unaffected siblings: a nationwide population-based study. J Am Acad Dermatol. 2020;82(5):1131–1137. PubMed CrossRef
  30. Li CY, Dai YX, Chang YT, et al. Prenatal exposure to acetaminophen increases the risk of atopic dermatitis in children: a nationwide nested case-control study in Taiwan. Pediatr Allergy Immunol. 2021;32(5):1080–1088. PubMed CrossRef
  31. Lin CC, Lai MS, Syu CY, et al. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005;104(3):157–163. PubMed
  32. Cheng CL, Kao YH, Lin SJ, et al. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–242. PubMed CrossRef
  33. Hsieh CY, Chen CH, Li CY, et al. Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database. J Formos Med Assoc. 2015;114(3):254–259. PubMed CrossRef
  34. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. PubMed CrossRef
  35. Matzer F, Egger JW, Kopera D. Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol. 2011;91(3):318–327. PubMed CrossRef
  36. Vallerand IA, Lewinson RT, Parsons LM, et al. Assessment of a bidirectional association between major depressive disorder and alopecia areata. JAMA Dermatol. 2019;155(4):475–479. PubMed CrossRef
  37. Colón EA, Popkin MK, Callies AL, et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry. 1991;32(3):245–251. PubMed CrossRef
  38. Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008;47(11):1118–1120. PubMed CrossRef
  39. Kang JH, Lin HC, Kao S, et al. Alopecia areata increases the risk of stroke: a 3-year follow-up study. Sci Rep. 2015;5(1):11718. PubMed CrossRef
  40. Tembhre MK, Sharma VK. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Br J Dermatol. 2013;169(3):543–548. PubMed CrossRef
  41. Atwa MA, Youssef N, Bayoumy NM. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity. Int J Dermatol. 2016;55(6):666–672. PubMed CrossRef
  42. Loh SH, Moon HN, Lew BL, et al. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol. 2018;32(6):1028–1033. PubMed CrossRef
  43. Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. PubMed CrossRef
  44. Ringheim GE, Szczepanik AM, Petko W, et al. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res Mol Brain Res. 1998;55(1):35–44. PubMed CrossRef
  45. Quintanilla RA, Orellana DI, González-Billault C, et al. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res. 2004;295(1):245–257. PubMed CrossRef
  46. Griffin WS, Barger SW. Neuroinflammatory cytokines—the common thread in Alzheimer’s pathogenesis. US Neurol. 2010;6(2):19–27. PubMed CrossRef
  47. Griffin WS, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86(19):7611–7615. PubMed CrossRef